RoundTable Healthcare, an operating-oriented private equity firm, and Signet Healthcare, provider of growth capital to innovative healthcare companies, completed the acquisition of Moberg Pharma's OTC business for $155m. "We are excited to announce this transformational transaction. The transaction delivers exceptional value for the OTC-business and further validates the significant potential in MOB-015. The proceeds from this transaction offer near-term liquidity to our shareholders while preserving future upside. I would like to commend and thank our team for all of their hard work. Over the last few years we have acquired, built and generated superior performance for the company, and those efforts are reflected in this transaction," Peter Wolpert, Moberg Pharma CEO.